Recent advances in combined modality therapy. [PDF]
Oncologist, 2010 Abstract Combined modality therapy emerged from preclinical data showing that carefully chosen drugs could enhance the sensitivity of tumor cells to radiation while having nonoverlapping toxicities. Recent advances in molecular biology involving the identification of cellular receptors, enzymes, and pathways involved in tumor growth and ...
Mierzwa ML +3 more
europepmc +10 more sources
Radiation-induced prodrug activation: extending combined modality therapy for some solid tumours. [PDF]
Br J Cancer, 2022 Combined chemoradiotherapy is the standard of care for locally advanced solid tumours. However, systemic toxicity may limit the delivery of planned chemotherapy. New approaches such as radiation-induced prodrug activation might diminish systemic toxicity,
Farrer NJ, Higgins GS, Kunkler IH.
europepmc +3 more sources
Combined Modality Therapy of Gemcitabine and Radiation [PDF]
The Oncologist, 2005 Abstract Learning Objectives After completing this course, the reader will be able to: List the advantages of combination chemotherapy and radiotherapy. Explain the rationale for doing in vitro research in the radiochemotherapy field.
Bea Pauwels +3 more
openalex +5 more sources
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
JAMA Oncol, 2018 Importance Combined-modality therapy with chemotherapy and radiation therapy plays a crucial role in the upfront treatment of patients with limited-stage small cell lung cancer (SCLC), but there may be barriers to utilization in the United States ...
Pezzi TA +9 more
europepmc +2 more sources
Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy. [PDF]
Ann Am Thorac Soc, 2016 Obstructive sleep apnea (OSA) is a common sleep disorder with serious associated morbidities. Although several treatment options are currently available, variable efficacy and adherence result in many patients either not being treated or receiving ...
Deacon NL, Jen R, Li Y, Malhotra A.
europepmc +2 more sources
Targeted radionuclide therapy in combined-modality regimens [PDF]
The Lancet Oncology, 2017 Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use of radioisotopes, radiolabelled molecules, nanoparticles, or microparticles that either naturally accumulate in or are designed to target tumours. TRT combines the specificity of molecular and sometimes physical targeting with the potent cytotoxicity of ionising ...
Gill, MR, Falzone, N, Du, Y, Vallis, KA
openaire +6 more sources
Prostatic Leiomyosarcoma: The Case for Combined Modality Therapy [PDF]
Sarcoma, 1997 Patient. A 65‐year old man who had previously undergone surgery for benign prostatic hyperplasia presented with symptoms of recurrent bladder outflow obstruction. Cystoscopy revealed the presence of recurrent tissue.Results. Histology identified a leiomyosarcoma.
Keith Vaughton, Salah El-Sharkawi
openaire +7 more sources
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy [PDF]
British Journal of Cancer, 2007 There is no consensus on the management of locally advanced pancreatic cancer, with either chemotherapy or combined modality approaches being employed (Maheshwari and Moser, 2005).
A Jemal +39 more
core +3 more sources
Editorial: Developing combined modality therapy with mitochondria-targeting strategy [PDF]
Frontiers in Oncology, 2023 Yong Teng, Yong Teng
doaj +2 more sources
Medulloblastoma: Results with combined modality therapy
International Journal of Radiation Oncology*Biology*Physics, 1989 The results of treatment of posterior fossa (PF) medulloblastomas treated at UCSF between 1966 and 1987 were analyzed. 65 patients (pts) were treated postoperatively with craniospinal radiation therapy (CS XRT). The PF dose was 54 Gy. Initially spinal doses of 30-40 Gy, cranial doses of 40-50 Gy were given. Late sequelae were noted.
F. Halberg +7 more
openalex +3 more sources